Navigation Links
Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
Date:10/17/2007

BRAINTREE, Mass., and TOKYO, Oct. 17 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) is pleased to announce that Keiko Hattori will join the Company effective October 22, 2007 as President, Haemonetics Japan. Ms. Hattori will replace Haemonetics Japan's current President, Ryoji Sakai, who previously announced plans to retire.

Brian Concannon, Haemonetics' Chief Operating Officer, said, "Ms. Hattori has tremendous experience and a proven track record for growing businesses in the Japanese and Asian healthcare markets. She brings a depth of leadership to the Japan organization and our senior management team. We are very excited to have someone of her capabilities joining us."

Ms. Hattori's professional background includes positions of increasing responsibility in sales, marketing, and management at several global healthcare companies. She joined Pharmacia in 1985 as Manager of Regulatory Affairs. She remained with Pharmacia when it was acquired by Amersham and ultimately became President of Amersham Biosciences KK. In 2004, when Amersham was acquired by GE she continued the role. Since then Ms. Hattori has held positions with increasing responsibility in various GE divisions in the U.S. and Asia.

Ms. Hattori, age 55, has a BS in Biochemistry from Tokyo University.

Mr. Concannon added, "I'd also like to thank Ryoji Sakai for his significant contributions to Haemonetics during his 13 years of service, as well as for his leadership in transforming our Japanese organization." Mr. Sakai will remain at Haemonetics through fiscal year end as an Executive Advisor to facilitate a smooth transition.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:

Julie Fallon

Tel. (781) 356-9517

Alternate Tel. (617) 320-2401

fallon@haemonetics.com


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Clintons new problem - Is the outgoing American president suffering from skin cancer?
10. Past President Narayanans Condition Still Critical
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 2016 , ... On Dec. 2, 2016, CURE® magazine will host the 4th ... 2016 MPN Heroes—eight individuals who have made a difference in the field of rare ... of care, demonstrating leadership within the MPN community and/or a commitment to individual patients. ...
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change ... Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch ... plan (Part D) need to make changes during this period order for their new ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, ... standing as living proof that attitude and determination can combine into the most ... spike around the holidays. This campaign will offer patients a new-found hope, by ...
(Date:12/2/2016)... ... 2016 , ... Mediaplanet is proud to announce the launch ... innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians ... years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... held the largest share in the ECG Cables And ... demand for remote monitoring ECG devices. On the other hand, ... to witness the highest growth rate during the forecast period. ... Dickinson and Company (U.S.), Medtronic plc ( Ireland ... and Mindray Medical International Limited ( China ), ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... Share, Development, Growth and Demand Forecast to 2022" report to their ... , , ... $6 billion in 2015, and it is expected to grow at a ... is expected to witness faster growth during the forecast period, a CAGR ...
(Date:12/2/2016)... SAN FRANCISCO , Dec. 2, 2016  PipelineRx, ... clinical telepharmacy, will be offering demonstrations of its ... American Society of Health-System Pharmacists 2016 Midyear Clinical ... Las Vegas . With nearly 300 hospital ... telepharmacy services and technology designed to dramatically improve ...
Breaking Medicine Technology: